Coldstream Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.34M | Buy |
38,522
+5,714
| +17% | +$333K | 0.03% | 255 |
|
|
2025
Q4 | $1.77M | Sell |
32,808
-5,129
| -14% | -$247K | 0.02% | 312 |
|
|
2025
Q3 | $1.71M | Buy |
37,937
+9,329
| +33% | +$436K | 0.02% | 338 |
|
|
2025
Q2 | $1.32M | Sell |
28,608
-6,625
| -19% | -$325K | 0.02% | 358 |
|
|
2025
Q1 | $2.15M | Sell |
35,233
-1,054
| -3% | -$61.4K | 0.05% | 233 |
|
|
2024
Q4 | $2.05M | Buy |
36,287
+7,154
| +25% | +$400K | 0.04% | 238 |
|
|
2024
Q3 | $1.53M | Buy |
29,133
+9,324
| +47% | +$437K | 0.03% | 281 |
|
|
2024
Q2 | $823K | Sell |
19,809
-348
| -2% | -$15.6K | 0.02% | 369 |
|
|
2024
Q1 | $1.09M | Sell |
20,157
-1,966
| -9% | -$100K | 0.03% | 309 |
|
|
2023
Q4 | $1.14M | Sell |
22,123
-6,370
| -22% | -$334K | 0.03% | 269 |
|
|
2023
Q3 | $1.65M | Sell |
28,493
-50,016
| -64% | -$3.06M | 0.05% | 190 |
|
|
2023
Q2 | $5.02M | Buy |
78,509
+5,231
| +7% | +$351K | 0.16% | 94 |
|
|
2023
Q1 | $5.08M | Buy |
73,278
+44,530
| +155% | +$3.14M | 0.17% | 94 |
|
|
2022
Q4 | $2.07M | Buy |
+28,748
| New | +$2.17M | 0.08% | 160 |
|
|
2022
Q2 | $1.74M | Buy |
22,623
+4,325
| +24% | +$329K | 0.07% | 156 |
|
|
2022
Q1 | $1.34M | Sell |
18,298
-262
| -1% | -$17.6K | 0.05% | 208 |
|
|
2021
Q4 | $1.16M | Buy |
18,560
+2,484
| +15% | +$146K | 0.04% | 226 |
|
|
2021
Q3 | $969K | Buy |
16,076
+2,469
| +18% | +$163K | 0.05% | 180 |
|
|
2021
Q2 | $909K | Sell |
13,607
-3,688
| -21% | -$240K | 0.04% | 211 |
|
|
2021
Q1 | $1.09M | Buy |
17,295
+688
| +4% | +$42.8K | 0.06% | 167 |
|
|
2020
Q4 | $1.03M | Buy |
16,607
+3,130
| +23% | +$192K | 0.06% | 162 |
|
|
2020
Q3 | $812K | Sell |
13,477
-157
| -1% | -$9.45K | 0.07% | 158 |
|
|
2020
Q2 | $802K | Buy |
13,634
+536
| +4% | +$32.1K | 0.07% | 156 |
|
|
2020
Q1 | $730K | Sell |
13,098
-215
| -2% | -$13.1K | 0.08% | 133 |
|
|
2019
Q4 | $854K | Buy |
13,313
+4,066
| +44% | +$233K | 0.07% | 159 |
|
|
2019
Q3 | $468K | Buy |
9,247
+422
| +5% | +$19.8K | 0.04% | 200 |
|
|
2019
Q2 | $400K | Sell |
8,825
-1,048
| -11% | -$48.8K | 0.03% | 217 |
|
|
2019
Q1 | $471K | Sell |
9,873
-918
| -9% | -$45.7K | 0.04% | 197 |
|
|
2018
Q4 | $561K | Sell |
10,791
-364
| -3% | -$19.6K | 0.05% | 188 |
|
|
2018
Q3 | $693K | Sell |
11,155
-132
| -1% | -$7.83K | 0.06% | 179 |
|
|
2018
Q2 | $625K | Sell |
11,287
-1,189
| -10% | -$64.2K | 0.06% | 177 |
|
|
2018
Q1 | $790K | Buy |
12,476
+275
| +2% | +$17.7K | 0.09% | 144 |
|
|
2017
Q4 | $748K | Sell |
12,201
-1,516
| -11% | -$94.8K | 0.08% | 155 |
|
|
2017
Q3 | $874K | Buy |
13,717
+1,062
| +8% | +$62K | 0.1% | 118 |
|
|
2017
Q2 | $705K | Buy |
12,655
+680
| +6% | +$37K | 0.09% | 137 |
|
|
2017
Q1 | $651K | Buy |
11,975
+360
| +3% | +$19.7K | 0.09% | 130 |
|
|
2016
Q4 | $679K | Buy |
11,615
+138
| +1% | +$7.54K | 0.11% | 106 |
|
|
2016
Q3 | $619K | Sell |
11,477
-574
| -5% | -$36.9K | 0.11% | 107 |
|
|
2016
Q2 | $886K | Sell |
12,051
-509
| -4% | -$36K | 0.16% | 102 |
|
|
2016
Q1 | $802K | Buy |
12,560
+2,720
| +28% | +$172K | 0.15% | 94 |
|
|
2015
Q4 | $677K | Buy |
9,840
+192
| +2% | +$12.7K | 0.15% | 89 |
|
|
2015
Q3 | $571K | Buy |
9,648
+3,128
| +48% | +$198K | 0.15% | 95 |
|
|
2015
Q2 | $434K | Buy |
6,520
+891
| +16% | +$58.7K | 0.11% | 99 |
|
|
2015
Q1 | $363K | Sell |
5,629
-879
| -14% | -$55K | 0.1% | 99 |
|
|
2014
Q4 | $384K | Buy |
6,508
+11
| +0.2% | +$620 | 0.11% | 108 |
|
|
2014
Q3 | $333K | Sell |
6,497
-125
| -2% | -$6.24K | 0.09% | 114 |
|
|
2014
Q2 | $321K | Buy |
6,622
+994
| +18% | +$49K | 0.09% | 121 |
|
|
2014
Q1 | $292K | Sell |
5,628
-146
| -3% | -$7.77K | 0.09% | 120 |
|
|
2013
Q4 | $307K | Sell |
5,774
-564
| -9% | -$28.7K | 0.1% | 120 |
|
|
2013
Q3 | $293K | Sell |
6,338
-263
| -4% | -$11.5K | 0.1% | 120 |
|
|
2013
Q2 | $295K | Buy |
+6,601
| New | +$287K | 0.1% | 124 |
|
Other funds holding BMY
VCM
VPM
Coldstream Capital Management's BMY Position: Q1 2026 in Review
Coldstream Capital Management increased its Bristol-Myers Squibb (BMY) stake by 17% in Q1 2026, buying an estimated $333K and bringing the position to 38,522 shares worth $2.34M. The position accounts for 0.03% of the portfolio, ranked #255.
Coldstream Capital Management first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.08M in Q1 2023. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Coldstream Capital Management held 38,522 shares of Bristol-Myers Squibb worth $2.34M as of Q1 2026.
- Coldstream Capital Management bought 5,714 Bristol-Myers Squibb shares in Q1 2026, an estimated $333K.
- Bristol-Myers Squibb made up 0.03% of Coldstream Capital Management's portfolio in Q1 2026, its #255 holding.
- Coldstream Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
- Coldstream Capital Management's Bristol-Myers Squibb position peaked at $5.08M in Q1 2023.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.